Baugh, Aaron G.
Gonzalez, Edgar
Narumi, Valerie H.
Kreger, Jesse
Liu, Yingtong
Rafie, Christine
Castanon, Sofi
Jang, Julie
Kagohara, Luciane T.
Anastasiadou, Dimitra P.
Leatherman, James
Armstrong, Todd
Chan, Isaac
Karagiannis, George S.
Jaffee, Elizabeth M.
MacLean, Adam
Torres, Evanthia T. Roussos
Funding for this research was provided by:
National Cancer Institute (P50CA062924, P30CA013330, P50CA062924, P30CA014089)
The Commonwealth Foundation for Cancer Research
The Allegheny Foundation
The Integrated Imaging Program for Cancer Research IIPCR
The Evelyn-Lipper Charitable Foundation
The Montefiore-Einstein Comprehensive Cancer Center (MECC) start-up fund
The EGL Charitable Foundation
The Emerson Foundation
Tower Cancer Research Foundation Career Development Award
Concern Foundation Conquer Cancer Now Award
University of Southern California
Article History
Received: 11 March 2024
Accepted: 21 April 2024
First Online: 8 May 2024
Declarations
:
: EMJ is a paid consultant for Adaptive Biotech, CSTONE, Achilles, DragonFly, and Genocea. She receives funding from Lustgarten Foundation and Bristol Myer Squibb. She is the Chief Medical Advisor for Lustgarten and SAB advisor to the Parker Institute for Cancer Immunotherapy (PICI) and for the C3 Cancer Institute.
: All animal studies were approved by the Institutional Review Board of USC and Johns Hopkins University.